About
Treatment for Peripheral Artery Disease
NovaPulse is a bioconvergence company specializing in the multibillion-dollar peripheral artery disease market. The company is focused on helping the millions of claudication patients who suffer from pain and have trouble walking because of insufficient blood supply to their legs.
NovaPulse is the brainchild of the MEDX Xelerator incubator.
Identity
| Name | NovaPulse |
|---|---|
| Slug | novapulse |
| Type / kind | startup |
| Source _id | JMwA8hRe91tZD1s6cE70RapoDU2WJtByNPX1y61bfwmVFzdVr02Ndb |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Or Yehuda |
| HQ address | Ariel Sharon Blvd 8, Or Yehuda, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2CB2B
Tags
bioconvergencecardiologyheart-diseases
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}